Exercise Program in Women With Metabolic Syndrome
2 de novembro de 2017 atualizado por: Vera Novak, Beth Israel Deaconess Medical Center
The Effect of Mixed Aerobic and Strength Training Program on Physical Fitness and Cerebrovascular Function in Older Women With Metabolic Syndrome: A Pilot Study With Randomized Control Trial (RCT) Design
The purpose of this study is to test whether a supervised mixed aerobic and strength training (MAST) program is effective in improving overall physical fitness and blood flow in the brain and lowering risk factors of coronary artery disease (CAD) in women with metabolic syndrome.
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Descrição detalhada
Metabolic syndrome is a cluster of conditions and disorders that increase the risk for coronary artery disease (CAD) and strokes.
Sedentary lifestyle is one of the risk factors, which decrease overall physical fitness and together with aging may lead to decrease in physical functioning in everyday life as well as changes in blood flow in the brain and cognitive functions.
Regular physical activity is associated with a reduced risk of cardiovascular disease.
It may also improve blood flow velocity and cognitive functions.
Physical activity should be as effective as possible, but also as safe as possible.
Supervised mixed aerobic and strength training (MAST) program for 4 months enables to individualize the intensity of aerobic exercise based on measured maximal exercise capacity.
Throughout each training session heart rate will be monitored with a new real time wireless ECG system.
Tipo de estudo
Intervencional
Inscrição (Real)
28
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02215
- Beth Israel Deaconess Medical Center, Harvard University
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
50 anos e mais velhos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Fêmea
Descrição
Inclusion Criteria:
- Post-menopausal women
- Age 50 or over
- Diagnosed metabolic syndrome
Exclusion Criteria:
- Any unstable or acute medical condition that the study physician deem unsafe for participation
- Positive stress test for CAD or other ischemic conditions
- Myocardial infarction or major surgery within 6 months
- History of a clinically documented stroke
- Clinical dementia (by history) or inability to follow details of the protocol
- Carotid stenosis > 50% by medical history
- Insulin dependent diabetes mellitus (also type II, if using insulin) or history of severe hypoglycemic episodes within 6 months requiring hospitalization
- Liver or renal failure or transplant
- Severe blood pressure elevation (systolic BP > 180 and/or diastolic BP > 110 mm Hg)
- Anemia (Hb < 10)
- Seizure disorders
- Current recreational drug or alcohol abuse
- BMI > 45, but body weight under 280 lbs
- Inability to obtain permission for participation from the primary care physician
- Clinically significant and movement limiting hip, knee and/or back disorders or injury, and rheumatoid arthritis
- Transcranial Doppler (TCD) exclusion criteria - poor insonation window and TCD signal
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Outro
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: MAST program
Mixed Aerobic and Strength Training program (MAST): Each exercise session consisted of 10 minutes of warm-up, 15-30 minutes of interval aerobic training by cycle ergometer according to the program, 20 minutes of strength training exercises, and 10 minutes of cool-down by stretching.
|
MAST program: twice a week for 4 months
|
|
Sem intervenção: UC
Usual Care (UC) with Educational Lectures: No exercise sessions.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Maximal Oxygen Uptake
Prazo: At baseline and after 4 months of intervention
|
To obtain peak oxygen uptake (VO2max; ml-1/min-1/kg), a symptom-limited exercise stress test was performed on a cycle ergometer.
The test was preceded by a 2-minute warm-up at the intensity of 20 W. The first test load was 20 W, and was increased by 20 W at each 2-minute stage until the participants could no longer continue, i.e., they were unable to maintain pedaling frequency > 40 rpm, they achieved a respiratory exchange ratio of more than 1.0, or clinical criteria for test termination was observed.
VO2max was measured and monitored with a breath-by-breath gas exchange system.
|
At baseline and after 4 months of intervention
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Cerebral Blood Flow Velocity (BFV)
Prazo: At baseline and after 4 months of intervention
|
Cerebral BFV was monitored using Transcranial Doppler Ultrasound.11
The middle cerebral artery was insonated from the temporal window by placing the 2-MegaHertZ (MHz) probe against the skin of the temporal region above the zygomatic arch.
The probe was positioned to obtain maximal BFV and was fixed at the desired angle using a 3-dimensional positioning system.
Once instrumented, BFV was continuously recorded throughout ten minutes of supine rest and 10-minutes on a table tilted to 80° from the horizontal position (head-up with foot plate support).
|
At baseline and after 4 months of intervention
|
|
Trail Making Test
Prazo: At baseline and after 4 months of intervention
|
The Trail Making (TM) test is a measure of shifting attention.
Participants are required to sequentially connect a series of numbered circles (Part A), and then to alternate between numbers and letters sequentially (Part B) (e.g., A-1-B-2-C-3..).
Any participant who has not completed Part B within the standard 5 minutes (300 seconds) allotted for the task will be considered unable to complete the task.
The scores in Part A (TM-A), Part B (TM-B) T scores ( age, education adjusted), and their difference (TM-B -TM-A) were calculated and used to measure executive function, i.e., lower scores indicates better performance.
|
At baseline and after 4 months of intervention
|
|
Muscle Strength
Prazo: At baseline and after 4 months of intervention
|
MAST sessions were held twice a week for 16 weeks.
Each exercise session consisted of 10 min of warm-up, 15-30 min of interval aerobic training by cycle ergometer according to the program, 20 min of strength training exercises, and 10 min of cool-down by stretching.
The target heart rate (HR) increased progressively from 50% up to 80% of HR reserve by the end of the intervention period.The Karvonen formula ([(HRmax - HRrest)×(0.50 to 0.80)] + HRrest) was used to calculate the target HR.
During every training session a new wireless computerized ECG monitoring system was used.
After aerobic training, the strength training program was performed.
Exercises used body mass as resistance and included squat, step-up-squat, step-up, heel rise, and sit-ups.
Dumbbells were used as extra weight (5 or 10% of body weight) during other exercises except for sit-ups.
The control group participated in an educational session once a month and kept physical activity diaries during the intervention period.
|
At baseline and after 4 months of intervention
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: Vera Novak, MD, PhD, Beth Israel Deaconess Medical Center
Publicações e links úteis
A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo
1 de julho de 2009
Conclusão Primária (Real)
1 de maio de 2010
Conclusão do estudo (Real)
1 de dezembro de 2013
Datas de inscrição no estudo
Enviado pela primeira vez
26 de junho de 2009
Enviado pela primeira vez que atendeu aos critérios de CQ
26 de junho de 2009
Primeira postagem (Estimativa)
29 de junho de 2009
Atualizações de registro de estudo
Última Atualização Postada (Real)
13 de novembro de 2017
Última atualização enviada que atendeu aos critérios de controle de qualidade
2 de novembro de 2017
Última verificação
1 de novembro de 2017
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2009P000121
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .